![Colin Love](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Colin Love
Directeur/Membre du Conseil chez
Replimune Ltd.
Profil
Colin A. Love was the founder of Replimune Group, Inc. (founded in 2015) where he held the title of Chief Operating Officer from 2015 to 2024.
He is currently working as a Non-Executive Director at Freeline Therapeutics Ltd., as a Director at Replimune Ltd., and as a Director at Replimune (Ireland) Ltd. Dr. Love has previously worked as a Director-Manufacturing Development at Celltech Group Plc, as an Independent Non-Executive Director at Freeline Therapeutics Holdings Plc from 2021 to 2024, as a Vice President-Clinical Operations at Amgen, Inc. from 2011 to 2014, as a Senior Vice President-Product Development at BioVex, Inc. from 2000 to 2011, as a Senior Vice President-Product Development at BioVex Group, Inc. from 2000 to 2013, and as a Senior Vice President-Product Development at BioVex Ltd. Dr. Love has an undergraduate and doctorate degree from the University of Glasgow.
Postes actifs de Colin Love
| Sociétés | Poste | Début |
|---|---|---|
Replimune Ltd.
 Replimune Ltd. Miscellaneous Commercial ServicesCommercial Services Research and develops cancer therapeutics | Directeur/Membre du Conseil | 10/07/2017 |
Replimune (Ireland) Ltd.
 Replimune (Ireland) Ltd. Miscellaneous Commercial ServicesCommercial Services Provides professional, scientific and technical services | Directeur/Membre du Conseil | 01/10/2019 |
Freeline Therapeutics Ltd.
 Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which developing gene therapies for bleeding and other debilitating disorders | Directeur/Membre du Conseil | - |
Anciens postes connus de Colin Love
| Sociétés | Poste | Fin |
|---|---|---|
| REPLIMUNE GROUP, INC. | Fondateur | 31/05/2024 |
BioVex Ltd.
 BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes biological treatments for cancer and infectious diseases | Corporate Officer/Principal | 31/07/2015 |
| AMGEN INC. | Directeur Technique/Scientifique/R&D | 01/01/2014 |
BioVex Group, Inc.
 BioVex Group, Inc. BiotechnologyHealth Technology Develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases | Corporate Officer/Principal | 24/01/2013 |
BioVex, Inc.
 BioVex, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases | Corporate Officer/Principal | 01/01/2011 |
Formation de Colin Love
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
46
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Celltech Group Plc
 Celltech Group Plc BiotechnologyHealth Technology Develops and manufactures pharmaceuticals | Health Technology |
BioVex, Inc.
BioVex, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases | Health Technology |
BioVex Group, Inc.
BioVex Group, Inc. BiotechnologyHealth Technology Develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases | Health Technology |
University of Glasgow
 University of Glasgow Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioVex Ltd.
BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes biological treatments for cancer and infectious diseases | Commercial Services |
Replimune Group, Inc.
 Replimune Group, Inc. BiotechnologyHealth Technology Develops oncolytic immunotherapies | Health Technology |
Freeline Therapeutics Ltd.
Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which developing gene therapies for bleeding and other debilitating disorders | Health Technology |
Replimune Ltd.
Replimune Ltd. Miscellaneous Commercial ServicesCommercial Services Research and develops cancer therapeutics | Commercial Services |
Replimune (Ireland) Ltd.
Replimune (Ireland) Ltd. Miscellaneous Commercial ServicesCommercial Services Provides professional, scientific and technical services | Commercial Services |
Freeline Therapeutics Holdings Plc
 Freeline Therapeutics Holdings Plc Pharmaceuticals: MajorHealth Technology Develops and manufactures next-generation gene therapies | Health Technology |
